Teva Pharmaceutical Industries Ltd.
TEVA | TA
Overview
Corporate Details
- ISIN(s):
- US8816242098 (+1 more)
- LEI:
- 549300BAFGM4RC74ZJ94
- Country:
- Israel
- Address:
- 124 DVORA HANEVIA, 6944020 TEL AVIV
- Website:
- https://www.tevapharm.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Teva Pharmaceutical Industries Ltd. is a global leader in the pharmaceutical industry, headquartered in Israel. Established in 1944, Teva specializes in the development, production, and marketing of generic and specialty medicines. The company has a diverse portfolio that includes treatments for central nervous system disorders, pain relief, respiratory conditions, and oncology. Teva is particularly known for its expertise in generic medicines, being one of the largest manufacturers in the world. The company’s innovative approach and extensive research and development capabilities have enabled it to introduce a wide range of affordable healthcare solutions, improving patient access to essential medicines worldwide.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-06 01:14 |
Takeover Announcement Report
Immediate Report
|
English | 338.5 KB | |
| 2025-08-06 01:14 |
Regulatory News Service
Immediate Report
|
English | 36.3 KB | |
| 2025-08-06 01:13 |
Takeover Announcement Report
Immediate Report
|
English | 340.1 KB | |
| 2025-08-06 01:13 |
Regulatory News Service
Immediate Report
|
English | 36.3 KB | |
| 2025-07-31 01:15 |
Quarterly Report
FORM 10Q-FINANCIAL STATEMENTS -Q2/25
|
English | 352.1 KB | |
| 2025-07-31 01:15 |
Regulatory News Service
FORM 10Q-FINANCIAL STATEMENTS -Q2/25
|
English | 36.5 KB | |
| 2025-07-30 16:15 |
Takeover Announcement Report
Reports 2025 Second Quarter Financial Results
|
English | 4.6 MB | |
| 2025-07-30 16:15 |
Regulatory News Service
Reports 2025 Second Quarter Financial Results
|
English | 36.4 KB | |
| 2025-07-30 16:09 |
Regulatory News Service
The company's financial results for the second quarter 2025 reported abroad
|
Hebrew (modern) | 62.5 KB | |
| 2025-06-17 01:12 |
Takeover Announcement Report
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Kalif Eliyahu…
|
English | 337.8 KB | |
| 2025-06-17 01:12 |
Regulatory News Service
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Kalif Eliyahu…
|
English | 36.3 KB | |
| 2025-06-10 01:42 |
Takeover Announcement Report
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Vergis Janet S
|
English | 337.4 KB | |
| 2025-06-10 01:42 |
Regulatory News Service
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Vergis Janet S
|
English | 36.3 KB | |
| 2025-06-10 01:42 |
Takeover Announcement Report
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Zaks Tal Zvi
|
English | 337.3 KB | |
| 2025-06-10 01:42 |
Regulatory News Service
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Zaks Tal Zvi
|
English | 36.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |